Surprisingly, unlike RNA viruses, blocking the nuclear export pathway using the XPO1 inhibitor LMB in human cancer cells significantly increased MYXV replication, similar to what we observed with the knockdown of DHX9 (21). This evidence concerns the gene XPO1 and cancer.